Issuer · CIK 0001626971

CRVS — Corvus Pharmaceuticals, Inc.

Recent filings

May 20, 2026·Form 4·Buy$60.3K
CRVS/Corvus Pharmaceuticals, Inc.
MILLER RICHARD A MD · President and CEO
Mechanical filing
AI thesis skipped

← Back to all filings

CRVS (Corvus Pharmaceuticals, Inc.) — recent insider filings — Form 4 AI